Resistell News:

Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.

Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.
Resistell News:

Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.

The Muttenz-based biotech startup proposes an alternative to culture-based antibiograms, the current gold standard in antibiotic susceptibility testing. The EPFL spin-off offers a diagnostic device, the rapid AST method, which is based on the detection of movement caused by living bacterial cells. The new method reduces the time taken to get a result from days to minutes, shows which specific antibiotic is effective against the bacteria, and significantly improves the chances of patients’ survival.
Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.
curves

Latest news

Swiss Diagnostics Startup Day
19th October 2017

Swiss Diagnostics Startup Day

A successful event with Solothurn
#Resistell
3rd August 2017

#Resistell

We are glad to inform all of you that the new poster with a Winner of the first Swissbiolabs Start-up Challenge is placed in front of the FHNW in Olten (Switzerland) !
Diagnostik Startup-ausgezeichnet · Resistell AG
3rd July 2017

Diagnostik Startup-ausgezeichnet · Resistell AG

Im Rahmen des ersten Swiss Diagnostics Start-Up Day 2017 an der Fachhochschule Nordwestschweiz präsentierten sechs Start-Ups aus der Biotechnologie und Diagnostik ihre Geschäftsideen einer Expertenjury.
Resistell was the winner of the first Swissbiolabs Challenge
28th June 2017

Resistell was the winner of the first Swissbiolabs Challenge

Congratulations to the Winner of the first Swissbiolabs Challenge, Danuta Cichocka for her great presentation and innovative idea!
#Resistell
3rd June 2017

#Resistell

It is estimated that at least 700 000 people die every year from the infections caused by antibiotic resistant bacteria. If no action is taken the death toll may reach 10 million a year by 2050. It is more than the number of people currently dying from road traffic accidents and cancer together.
#Resistell #Swissbiolabs #SWISSBIOLABSAWARD2017
11th May 2017

#Resistell #Swissbiolabs #SWISSBIOLABSAWARD2017

Congratulations to the Winner of the first Swissbiolabs Challenge, Danuta Cichocka for her great presentation and innovative idea!
#Resistell #Swissbiolabs #SWISSBIOLABSAWARD2017
11th May 2017

#Resistell #Swissbiolabs #SWISSBIOLABSAWARD2017

Danuta Cichocka from the winning company Resistell is awarded the Swissbiolabs Award 2017.